Globela Pharma Private Limited - Company Profile

It is a pharma private limited company based in Surat, Gujarat, India, established in 2006.
2006 Surat, Gujarat, India Active
Last Updated:
Access Report
About Globela Pharma Private Limited

Globela Pharma Private Limited, a active private limited company, was established on 08 February 2006 in Surat, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2006PTC047699. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹58.00 Cr and a paid-up capital of ₹56.92 Cr.

It upholds a compliant status. Employing 150 professional, Its leadership includes Mayur Anand Sirdesai (Director), Pietro Ermanno Stefanutti (Director), Bhanubhai Shambhubhai Vaghashia (Managing Director). Past directors included Krishna Tejashkumar Naik, Pragjibhai Gobarbhai Kakadia, Ravishanker Kovi. It holds ₹168.62 Cr open charges and ₹16.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 357 - 358, Road No. 3 Gidc, Sachin, Surat, Gujarat, 394230.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2006PTC047699

  • Registration Number

    047699

  • Incorporation Date

    08 February 2006

  • Authorized Capital

    ₹58.00 Cr

  • Paid-Up Capital

    ₹56.92 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 58.00 Cr
  • Paid Up Capital ₹ 56.92 Cr
  • Company Age 20 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 168.62 Cr
  • Satisfied Charges ₹ 16.00 Cr
  • Revenue Growth **** 14.16%
  • Profit Growth **** -24.90%
  • Ebitda **** -8.75%
  • Net Worth 7.62%
  • Total Assets **** 9.35%
Company report

Globela Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Globela Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Globela Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mayur Anand Sirdesai Director 23 Sep 2021 Current
Pietro Ermanno Stefanutti Director 13 Jan 2022 Current
Bhanubhai Shambhubhai Vaghashia Managing Director 08 Feb 2006 Current
Priyank Vaghashia Director 23 Sep 2021 Current
Urmilaben Bhanubhai Vaghasiya Director 25 Oct 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 25 Oct 2010 Past
Pramod Abcsdd Additional Director 10 Dec 2011 Past
Pramod Abcsdd Additional Director 23 Sep 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 23 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Globela Pharma.

Globela Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.16% increase. The company also saw a substantial fall in profitability, with a 24.9% decrease in profit. The company's net worth moved up by a moderate rise of 7.62%.

Globela Pharma revenue growth over time
Globela Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.16%
*******
*******
*******
*******
Revenue from Operations
*******
 17.01%
*******
*******
*******
*******
Total Assets
*******
 9.35%
*******
*******
*******
*******
Profit or Loss
*******
 -24.90%
*******
*******
*******
*******
Net Worth
*******
 7.62%
*******
*******
*******
*******
EBITDA
*******
 -8.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Globela Pharma?

In 2024, Globela Pharma had a promoter holding of 74.21% and a public holding of 25.79%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,686,200,000.00

Satisfied Charges

₹159,993,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 161.27 Cr
  • Sidbi : 7.35 Cr
Latest Charge Details
Date Lender Amount Status
05 Aug 2024 Sidbi ₹7.35 Cr Open
06 May 2022 Axis Bank Limited ₹22.06 Cr Open
25 Mar 2022 Axis Bank Limited ₹54.47 Cr Open
28 Mar 2017 Axis Bank Limited ₹42.37 Cr Open
29 Nov 2016 Axis Bank Limited ₹42.37 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Globela Pharma?

Globela Pharma has a workforce of 150 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Globela Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globela Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Globela Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Globela Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    A charge with Sidbi amounted to Rs. 7.35 Cr with Charge ID 100967171 was registered on 05 Aug 2024. was recorded as a recent event.

  • Balance Sheet

    The activity Globela Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 22.06 Cr registered on 06 May 2022 with Charge ID 100568822 was modified on 05 Mar 2024. was documented.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 54.47 Cr registered on 25 Mar 2022 with Charge ID 100554236 was modified on 09 Jan 2024. was completed.

  • Charges

    The activity A charge with Axis Bank Limited of Rs. 42.37 Cr registered on 29 Nov 2016 with Charge ID 100065045 was modified on 19 Dec 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Globela Pharma Private Limited?

The CIN of Globela Pharma Private Limited is U24230GJ2006PTC047699.

Where is Globela Pharma Private Limited headquartered?

Globela Pharma Private Limited is headquartered at Plot No. 357 - 358, Road No. 3 Gidc, Sachin, Surat, Gujarat, 394230.

When was Globela Pharma Private Limited incorporated?

Globela Pharma Private Limited was incorporated on 08 February 2006.

Who are the current directors of Globela Pharma Private Limited?

The current directors of Globela Pharma Private Limited are

What is the primary industry of Globela Pharma Private Limited?

The primary industry of Globela Pharma Private Limited is Manufacturing.

Is Globela Pharma Private Limited a listed company?

Globela Pharma Private Limited is unlisted.

What is the capital structure of Globela Pharma Private Limited?

The authorized capital of Globela Pharma Private Limited is ₹58.00 Cr, and the paid-up capital is ₹56.92 Cr.

What is the compliance status of Globela Pharma Private Limited?

The compliance status of Globela Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available